Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

NCT06935383 is registered in ClinicalTrials.gov with CorFlow Therapeutics AG as lead sponsor.

NCT NCT06935383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised EValuation of Therapies for microvAscuLar Injury in STEACS
Lead sponsor
CorFlow Therapeutics AG
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 30, 2027
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stemi (st elevation mi)